Midventricular hypertrophic cardiomyopathy

Article written and reviewed by Dr Luca Moretti

Midventricular hypertrophic cardiomyopathy is the phenotype in which dynamic narrowing develops in the midportion of the left ventricle rather than in the outflow tract. Systolic apposition of the hypertrophied walls, often together with bulky or malpositioned papillary muscles, divides the cavity into a basal chamber and an apical chamber. The intracavitary gradient must be localized precisely because the mechanism, complications and surgical approach differ from classic subaortic obstruction with SAM.

The apical portion distal to the narrowing may reach high systolic pressures while emptying only minimally toward the aorta. Wall stress, microvascular compression and oxygen demand promote ischemia and scarring. Over time, the apex may thin and become akinetic or dyskinetic, forming an aneurysm. The apical chamber is therefore not merely a residual space but a hemodynamic compartment capable of determining the natural history.

This form represents a minority of patients with HCM, with frequencies varying according to definition and imaging sensitivity. In cohorts with apical aneurysm, midventricular obstruction is much more common than is recognized during conventional echocardiography. The gradient may be difficult to record when obliteration is nearly complete or flow crosses a short channel. Underdiagnosis results mainly from failure to scan systematically from apex to base.

The phenotype may overlap with apical cardiomyopathy, but the two terms are not interchangeable. Apical HCM is defined by the distribution of wall thickness; the midventricular form by the site of narrowing and the gradient. A patient may have both, only one, or mixed hypertrophy. The combined description preserves information that a single label would lose and clarifies why an aneurysm may develop even in a morphology that is not classically apical.

Observational series associate midventricular obstruction with a higher risk of HCM-related death, arrhythmias and progression, especially when an aneurysm develops. These data come from selected populations and do not make an adverse outcome inevitable in every patient. They do, however, overcome the idea that a gradient remote from the outflow tract is a secondary finding. Dedicated risk stratification integrates anatomy, scar, rhythm, thrombus and function.

Anatomy, hemodynamics and aneurysm formation

The narrowing most often arises from contact between the midseptum and the free wall, sometimes completed by apposition of the papillary muscles. Hypertrophy may be annular, creating a type of muscular diaphragm, or asymmetric. The distal cavity varies in size and may become obliterated in systole. Three-dimensional anatomy is defined better by multiplanar cine imaging and contiguous short-axis slices than by a single longitudinal view.

During systole, the basal chamber ejects toward the aorta while the apical chamber encounters the narrowing. The pressure difference generates a high-velocity jet that may be short and difficult to align. Unlike LVOTO, mitral SAM may be absent and regurgitation is not the dominant mechanism. The Doppler profile must be assigned to its site before the velocity is converted into a gradient.

During relaxation, paradoxical diastolic flow from the apex toward the base may appear. It reflects delayed emptying of the apical chamber after the systolic gradient has fallen and is a clue to compartmentalization. The signal is not present in every patient and may be confused with other intracavitary flows. The diastolic jet becomes meaningful when linked to the morphology and systolic curve.

Apical pressure may be high even when the Doppler gradient is modest because near-complete obliteration limits the flow required to generate a measurable velocity. This apparent contradiction explains why a low measurement does not exclude distal stress. Cavity, scar and flow must be considered together. Occult hemodynamics may require selective catheterization when a surgical decision depends on pressure confirmation.

The apical microcirculation is exposed to compression, reduced reserve and high wall tension. Repeated ischemia causes myocyte death and replacement fibrosis, initially focal and then confluent. Nearly transmural scar may mimic an infarction in a coronary territory but does not necessarily follow the anatomy of an epicardial vessel. The ischemic injury must nevertheless be distinguished from concomitant coronary disease by appropriate evaluation.

When scarred tissue loses thickness and contractility, an aneurysm develops. The region may be small and only akinetic or large and dyskinetic, with a neck at the border of the midventricular segment. The border retains heterogeneous myocardium capable of supporting reentry. The apical aneurysm is therefore both a mechanical complication and an electrical and thrombotic substrate.

Stasis in the aneurysmal chamber promotes mural thrombi, sometimes laminated and difficult to distinguish from fibrotic endocardium. Emboli may involve the brain or peripheral circulation. Atrial fibrillation and atrial dilation add a second source of thrombus. Embolic risk requires accurate imaging and should not automatically be attributed to the aneurysm without searching for other causes.

Not all aneurysms are preceded by a documented midventricular gradient. The gradient may be intermittent, disappear when the apex becomes dyskinetic, or not be captured technically. Consequently, the absence of an old recording does not exclude the mechanism. Longitudinal reconstruction uses previous images, scar distribution and current anatomy to understand the trajectory.

The narrowing may predominantly involve the papillary muscles and create eccentric channels that axial Doppler does not intercept. In these cases the gradient varies with the imaging plane and the geometry appears less regular than circular apposition. Papillary obstruction must be recognized before surgery because isolated septal resection may leave the principal responsible element in place.

Midventricular hypertrophy increases mass and reduces compliance even when the gradient is modest. Symptoms and high filling pressures may therefore persist after effective anatomic correction. The dual pathophysiology, obstructive and diastolic, should be explained to the patient so that procedural outcome is not judged solely by disappearance of the velocity.

Echocardiographic diagnosis, magnetic resonance and hemodynamics

Echocardiography begins with a nonforeshortened apical view and color Doppler at an appropriate scale. The pulsed-wave sample is moved progressively from the apex to the outflow tract to localize acceleration; continuous-wave Doppler measures the maximum while aligned with the jet. Flow mapping prevents a midcavitary velocity from being attributed to the aortic valve or mitral regurgitation.

Intracavitary contrast is particularly useful when the apex is not visible, the cavity appears obliterated or an aneurysm is suspected. It outlines the border, shows communication between chambers and may identify a filling defect caused by thrombus. An organized thrombus may nevertheless require magnetic resonance for confirmation. Apical opacification should be acquired without excessive contrast destruction and in multiple views.

The gradient is calculated from velocity using the simplified Bernoulli equation, but the value assumes that proximal velocity is low and that the signal belongs to the correct jet. In the presence of two serial obstructions or aortic stenosis, the simple formula may be inaccurate. Envelope shape and the site of aliasing complete the measurement. Doppler quantification cannot be separated from anatomic localization.

Provocation with Valsalva or exercise may increase the narrowing, but safety and meaning must be considered when an aneurysm or important symptoms are already present. Exercise echocardiography documents capacity, blood pressure and dynamics, whereas a nearly closed chamber may remain difficult to interrogate. The physiologic response helps correlate dyspnea or presyncope with the gradient and exclude concomitant LVOTO.

Magnetic resonance provides the most complete definition of the midventricular walls, papillary muscles, distal chamber and aneurysm. Cine sequences show apposition and flow, whereas LGE identifies apical scar and its border. Thrombus sequences distinguish avascular material from myocardium. CMR is indispensable when echocardiography does not clarify the apex or before a complex surgical strategy.

Computed tomography can describe anatomy, coronary arteries and thrombus when magnetic resonance is contraindicated, but it uses radiation and iodine. Ventriculography may show separation between the chambers and the aneurysm during an invasive examination. Neither replaces echocardiography for dynamic changes. Multimodality imaging is selected to fill specific gaps rather than repeat measurements that are already reliable.

Catheterization with distal and proximal positioning can directly measure the pressure difference and apical pressure. It is reserved for discrepancies or planning because crossing an obliterated cavity requires expertise and may provoke ectopy. Coronary angiography assesses septal branches and epicardial disease. Invasive confirmation is valuable when it changes the indication, not as a routine step after concordant imaging.

ECG monitoring, exercise testing and laboratory studies complete the assessment. NSVT and monomorphic tachycardias may indicate an aneurysmal border, whereas natriuretic peptides and troponin reflect stress without specificity. Genetic testing and family screening follow the rules for HCM. The complete diagnosis should report etiology, sudden death risk and function in addition to the midventricular gradient.

Flow through the narrowing may be contaminated by mitral regurgitation or a coexisting outflow jet. Velocity and shape are therefore compared with color Doppler, sample location and duration. Signal discrimination avoids adding serial gradients or planning a procedure for a measurement belonging to another structure.

Three-dimensional echocardiography and CMR reconstruction help measure the length of the obstructive segment and its relationship with the papillary muscles. This information allows the surgeon to choose the access and depth of resection. Volumetric planning reduces the risk of leaving a residual cavity that is too small or creating a septal communication.

Manifestations, arrhythmias, thrombosis and prognosis

Dyspnea and exercise intolerance result from diastolic dysfunction, reduced cavity size, gradient and inability to increase output. Pain may reflect apical ischemia, whereas presyncope or syncope requires distinction among reduced output, arrhythmia and reflex causes. Symptom severity does not always track the maximum gradient. Cardiopulmonary exercise testing quantifies a limitation that resting imaging may not predict.

Ventricular tachycardias may arise from apical scar and present as recurrent monomorphic episodes. An aneurysm increases risk, but not every aneurysm produces arrhythmias, and arrhythmias may occur without a visible aneurysm. Frequency, duration and rate of NSVT integrate LGE, syncope and other markers. Substrate mapping is considered in patients with sustained episodes or uncontrolled shocks.

ICD assessment follows the general criteria for HCM and gives particular weight to aneurysm. HCM Risk-SCD may not fully represent this modifier, so the numerical result does not end the discussion. Secondary prevention remains a strong indication. Primary prevention weighs arrhythmic risk, age, device complications and preferences, avoiding both automatic decisions and underestimation.

Apical thrombus may be asymptomatic or present with embolism. When thrombus is documented, anticoagulation is started unless contraindicated, and imaging verifies the response. Subsequent duration depends on persistence of the aneurysm, recurrence and bleeding risk. Prophylaxis without thrombus is not supported by randomized trials and is individualized, especially in large aneurysms or those with marked stasis.

Atrial fibrillation worsens filling and embolic risk and requires anticoagulation regardless of CHA2DS2-VASc when clinically documented. Rhythm control may be particularly useful in a stiff ventricle despite frequent recurrences. Prolonged monitoring looks for episodes in the presence of atrial dilation or symptoms. Thromboembolism may originate from the atrium or ventricle, and one source does not exclude the other.

Cohorts have associated MVO with a higher risk of progression to end-stage disease and arrhythmic events than HCM without this feature. In one study, aneurysm was present in a substantial proportion and predicted HCM-related death; other series confirm an unfavorable phenotype, although selection varies. The observational evidence justifies intensive surveillance but does not allow deterministic prediction in an individual patient.

Function may deteriorate with scar, aneurysm and remodeling. An ejection fraction below 50% defines the systolic phase and requires heart failure therapy and assessment for advanced therapies. The cavity may remain small and make ventricular assist difficult. Hemodynamic progression should be recognized before fixed pulmonary hypertension or organ damage develops.

Follow-up compares the gradient, apex, LGE, thrombus, function and rhythm. New pain, syncope, palpitations or an embolic event prompt earlier assessment. Magnetic resonance is repeated when it can document evolution or modify ICD and anticoagulation decisions. A stable trajectory permits proportionate intervals but does not eliminate family screening or periodic risk stratification.

Chest pain with troponin requires distinction among microvascular ischemia, tachyarrhythmia and coronary syndrome. The presence of apical scar does not justify ignoring new epicardial obstruction. Coronary assessment follows age, pain characteristics and risk factors, preserving the possibility of treating a concomitant cause.

Aneurysm size may increase slowly and risk does not rise linearly. A small neck with scar may sustain arrhythmia, whereas a large chamber promotes stasis. Aneurysm phenotyping includes size, neck, motion, thrombus and LGE rather than using a single category.

Drug therapy, surgery and advanced management

Beta-blockers are used to reduce heart rate, contractility and gradient, with response assessed by symptoms and exercise. Verapamil or diltiazem may be alternatives when blood pressure and conduction permit. Disopyramide has a negative inotropic rationale but less extensive specific data than for LVOTO. Drug therapy is titrated while avoiding bradycardia and low output in an already compartmentalized cavity.

Myosin inhibitors have been studied and approved for symptomatic obstructive HCM defined predominantly by the outflow tract. Their specific efficacy on the midventricular gradient, aneurysm and scar prevention has not been established. Any use must respect the regulatory indication and specialist assessment without assuming equivalence between sites. Therapeutic extrapolation is particularly risky when the main problem is a fibrotic apical chamber.

Myectomy is considered in patients with severe symptoms attributable to obstruction despite medication. An extended transaortic approach may reach proximal midventricular segments; transapical access allows direct resection of midventricular muscle and enlargement of the distal cavity. Some anatomies require a combined approach. Surgical planning uses imaging models to avoid septal defects, papillary injury and insufficient resection.

Series of transapical myectomy report marked improvement in functional class and good survival at expert centers, but they are not randomized trials. Ventriculotomy, bleeding, arrhythmias and changes in apical function are specific risks. The procedure is not proposed on the basis of the gradient alone. Surgical selection requires refractory symptoms, a convincing mechanism and a favorable balance between benefit and complexity.

When an aneurysm coexists, surgery may include thrombectomy or repair in selected cases, especially when obstruction is already being treated. Resection of a small chamber may, however, further reduce volume and must be planned cautiously. Arrhythmic benefit is not guaranteed because residual scar may persist. Aneurysm repair is an individual choice and not an automatic component of myectomy.

Alcohol ablation is not the standard treatment for MVO because perfusion of the responsible segment is variable and the induced injury may not correspond to the narrowing. Selected cases have been treated, but additional scar in a phenotype already predisposed to aneurysm requires caution. Coronary contrast echocardiography would in any case be essential. Percutaneous septal reduction should not be transferred from LVOTO without a reliable anatomic target.

Recurrent ventricular tachycardia requires an ICD, appropriate programming, medication and possible ablation. The circuit may be endocardial, epicardial or intramural around the aneurysm, making an advanced strategy necessary. Ablation reduces recurrences but does not alter pressure or progression. Electrical therapy must be coordinated with hemodynamic and anticoagulant treatment.

In advanced disease, heart failure therapy and transplant assessment are guided by function, capacity and pulmonary pressure. Mechanical support is difficult with a small cavity and aneurysm and does not always provide a practicable bridge. Early referral preserves options. Multidisciplinary management integrates imaging, HCM surgery, electrophysiology, heart failure and genetics so that each complication is not treated in isolation.

Hypertension treatment should control load without producing hypotension or accentuating the gradient. Home measurements and assessment during activity guide titration. Systemic pressure is not left elevated to preserve flow artificially because, over the long term, it would promote mass, ischemia and atrial enlargement.

Surgical outcome is assessed using capacity, midventricular gradient, apical volume, function and arrhythmias. An enlarged chamber may improve output, but residual scar and aneurysm still require reassessment of ICD or anticoagulation indications. The composite outcome prevents success from being defined by a single hemodynamic measurement and guides subsequent rehabilitation.

Complications, follow-up and clinical communication

The complication most characteristic of the phenotype is aneurysm, but risk begins before it appears, with ischemia and scar. An apex that is still thick may already show extensive LGE and arrhythmias. Waiting for visible thinning misses a potentially informative phase. Pre-aneurysm surveillance considers pain, troponin, LGE and changes in motion without proposing unvalidated interventions.

An untreated thrombus may embolize; an anticoagulant exposes the patient to bleeding and interactions. Equivocal images should be clarified before indefinite therapy using contrast or magnetic resonance. After resolution, the cavity remains predisposed and requires a plan. Thrombus management includes a certain diagnosis, treatment, verification of resolution and reassessment of residual risk.

ICD shocks may be appropriate or inappropriate and affect quality of life. Rapid atrial fibrillation, detection thresholds and lack of antitachycardia therapy in some systems influence events. Device selection considers pacing requirements and the type of tachycardia. Personalized programming is particularly relevant when aneurysm-related arrhythmias are monomorphic and potentially terminable with pacing.

Physical activity is prescribed after assessment of symptoms, gradient, aneurysm and arrhythmias. The presence of aneurysm or tachycardia requires greater caution than a stable phenotype without scar. Dehydration and intense exertion may accentuate the gradient, but an absolute prohibition is not automatically necessary. Shared decision-making defines type, intensity, surveillance and stopping signals.

Pregnancy changes volume and heart rate and may destabilize pressure balance. Aneurysm, dysfunction, arrhythmias and anticoagulation increase complexity and require preconception assessment. Drug choice considers fetal safety and maternal risk. The cardio-obstetric team prepares delivery and the postpartum period while avoiding abrupt changes in preload.

Relatives should undergo screening without expecting the same midventricular morphology. The same variant may produce a septal or apical form or no phenotype, and a young relative may develop signs over time. Cascade testing is informative only when there is a causal variant. Familial heterogeneity makes it necessary to examine the entire ventricle rather than search only for the gradient observed in the proband.

The report should state the site and maximum gradient, provocative conditions, apical chamber dimensions, aneurysm, thrombus, LGE, function and arrhythmias. The generic phrase obstructive HCM does not convey these elements and may direct the patient toward standard ablation or myectomy that is unsuitable. Anatomic language is part of clinical safety, especially when the patient is assessed at multiple centers.

Prognosis should be explained without fatalism. MVO and aneurysm increase risk in cohorts, but imaging, anticoagulation, ICD, ablation and surgery provide concrete tools to modify complications. Scheduled follow-up allows the pathway to be updated before an event. Risk communication links each marker to possible actions and distinguishes what is proven from what remains uncertain.

Pregnancy requires assessment of the gradient, aneurysm, function and medications. Increased heart rate and volume changes may accentuate compartmentalization, whereas anticoagulation for thrombus or fibrillation complicates the plan. The cardio-obstetric pathway defines surveillance and delivery while avoiding abrupt changes in preload.

New four-dimensional flow techniques and computational models may clarify pressures and vortices but are not yet necessary in routine practice. They must demonstrate that the added information changes a decision or outcome. Imaging innovation complements, without replacing, validated color Doppler, magnetic resonance and clinical judgment.